Inventor · disambiguated record
James Barsoum
Also filed as: BARSOUM JAMES · BARSOUM JAMES G · BARSOUM JAMES GREGORY
27 granted patents·13 pending applications·2,400 citations·filing 1988–2022
98Inventor score
Files withBIOGEN INC12ARRAKIS THERAPEUTICS INC4SYNTA PHARMACEUTICALS CORP4BIOGEN IDEC INC3GEN HOSPITAL CORP3
Top patents by PatentIndex Score
40 records- 0198US5747641ATat-derived transport polypeptide conjugatesBIOGEN INC·Filed 1995·Granted May 5, 1998·319 cites·5 claims
- 0298US5674980AFusion protein comprising tat-derived transport moietyBIOGEN INC·Filed 1995·Granted Oct 7, 1997·349 cites·10 claims
- 0397US5804604ATat-derived transport polypeptides and fusion proteinsBIOGEN INC·Filed 1995·Granted Sep 8, 1998·470 cites·14 claims
- 0497US5652122ANucleic acids encoding and methods of making tat-derived transport polypeptidesFiled 1995·Granted Jul 29, 1997·286 cites·9 claims
- 0596US7825148B2Triazole compounds that modulate Hsp90 activitySYNTA PHARMACEUTICALS CORP·Filed 2005·Granted Nov 2, 2010·53 cites·51 claims
- 0696US5670617ANucleic acid conjugates of tat-derived transport polypeptidesBIOGEN INC·Filed 1995·Granted Sep 23, 1997·189 cites·4 claims
- 0795US4956288AMethod for producing cells containing stably integrated foreign DNA at a high copy number, the cells produced by this method, and the use of these cells to produce the polypeptides coded for by the foreign DNABIOGEN INC·Filed 1988·Granted Sep 11, 1990·225 cites·20 claims
- 0894US7662813B2Triazole compounds that modulate HSP90 activitySYNTA PHARMACEUTICALS CORP·Filed 2006·Granted Feb 16, 2010·35 cites·35 claims
- 0994US6316003B1Tat-derived transport polypeptidesWHITEHEAD BIOMEDICAL INST·Filed 1994·Granted Nov 13, 2001·174 cites·11 claims
- 1093US8362055B2Triazole compounds that modulate HSP90 activitySYNTA PHARMACEUTICALS INC·Filed 2010·Granted Jan 29, 2013·25 cites·20 claims
- 1190US10174328B2Compositions and methods for treating amyotrophic lateral sclerosisTRANSLATE BIO MA INC·Filed 2014·Granted Jan 8, 2019·7 cites·45 claims
- 1288US6190887B1Expression of an exogenous gene in a mammalian cell by use of a non-mammalian DNA virus having an altered coat proteinGEN HOSPITAL CORP·Filed 2000·Granted Feb 20, 2001·29 cites·21 claims
- 1387US6338953B1Expression of an exogenous gene in a mammalian cell by use of a non-mammalian DNA virus having an altered coat proteinGEN HOSPITAL CORP·Filed 1997·Granted Jan 15, 2002·63 cites·18 claims
- 1486US8901308B2Triazole compounds that modulate Hsp90 activityYING WEIWEN·Filed 2012·Granted Dec 2, 2014·7 cites·2 claims
- 1585US9090569B2Triazone compounds that modulate HSP90 activityYING WEIWEN·Filed 2009·Granted Jul 28, 2015·5 cites·19 claims
- 1682US5219990APapillomavirus e2 trans-activation repressorsBIOGEN INC·Filed 1991·Granted Jun 15, 1993·37 cites·6 claims
- 1781US6696423B1Methods and compositions for therapies using genes encoding secreted proteins such as interferon-betaBIOGEN INC·Filed 2000·Granted Feb 24, 2004·14 cites·12 claims
- 1880US9910031B2Compositions and methods for modulating c-Rel-dependent cytokine productionSYNTA PHARMACEUTICALS CORP·Filed 2014·Granted Mar 6, 2018·3 cites·18 claims
- 1978US5616559APapillomavirus E2 trans-activation repressorsBIOGEN INC·Filed 1995·Granted Apr 1, 1997·23 cites·3 claims
- 2077US6183993B1Complement-resistant non-mammalian DNA viruses and uses thereofGEN HOSPITAL CORP·Filed 1999·Granted Feb 6, 2001·40 cites·45 claims
- 2175US5667965APapillomavirus E2 trans-activation repressorsBIOGEN INC·Filed 1995·Granted Sep 16, 1997·18 cites·1 claims
- 2272US7534424B2Method of enhancing delivery of a therapeutic nucleic acidBIOGEN IDEC INC·Filed 2003·Granted May 19, 2009·2 cites·11 claims
- 2370US7256181B2Methods and compositions for therapies using genes encoding secreted proteins such as interferon-betaBIOGEN IDEC INC·Filed 2003·Granted Aug 14, 2007·4 cites·31 claims
- 2469US6326183B1Chromatographically concentrated baculovirus and methodsBIOGEN INC·Filed 2000·Granted Dec 4, 2001·1 cites·21 claims
- 2569US2021140945A1Methods of treating neurological diseases and disordersMADRIGAL PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2662US2008227114A1Compositions and methods for modulating c-rel-dependent cytokine productionSYNTA PHARMACEUTICALS CORP·Filed 2008·Application pending·0 cites
- 2762US2022402883A1Compounds and methods for modulating rna functionARRAKIS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2861US2018217130A1Compositions and methods for treating systemic lupus erythematosusMADRIGAL PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2960US2022281860A1Compounds and methods of treating rna-mediated diseasesARRAKIS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3056US5656599APapillomavirus E2 trans-activation repressorsBIOGEN INC·Filed 1995·Granted Aug 12, 1997·14 cites·5 claims
- 3156US2005282232A1Compositions and methods for modulating c-Rel-dependent cytokine productionLU RONGZHEN·Filed 2004·Application pending·0 cites
- 3255US5595884APapillomavirus E2 transactivation repressor proteins and DNABIOGEN INC·Filed 1992·Granted Jan 21, 1997·8 cites·17 claims
- 3355US2012208203A1Compositions and methods for modulating c-rel-dependent cytokine productionLU RONGZHEN·Filed 2012·Application pending·0 cites
- 3449US2020115372A1Compounds and methods of treating rna-mediated diseasesARRAKIS THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3544US2019194150A1Compounds and methods for modulating rna functionARRAKIS THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3642US2016122760A1Compositions and methods for modulating foxp3 expressionRANA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 3738US8148426B2Bis(thio-hydrazide amides) for increasing Hsp70 expressionBARSOUM JAMES·Filed 2005·Granted Apr 3, 2012·0 cites·22 claims
- 3838US2009042991A1Methods of increasing natural killer cell activity for therapyBARSOUM JAMES·Filed 2006·Application pending·0 cites
- 3938US2008193484A1Novel Methods for Producing Adenoviral Vector Preparations with Reduced Replication-Competent Adenovirus Contamination and Novel Adenoviral Vectors and PreparationsBIOGEN IDEC INC·Filed 2005·Application pending·0 cites
- 4034US2019055553A1Methods for identifying and targeting non-coding rna scaffoldsTRANSLATE BIO MA INC·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →